This Article Full Text Full Text (PDF) All Versions of this Article: 49/4/818    most recent 01.HYP.0000258404.21552.a3v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stepan, H. Articles by Faber, R. Search for Related Content PubMed PubMed Citation Articles by Stepan, H. Articles by Faber, R. Related Collections Angiogenesis Clinical Studies Other diagnostic testing

(Hypertension. 2007;49:818.)
© 2007 American Heart Association, Inc.

Original Articles

Predictive Value of Maternal Angiogenic Factors in Second Trimester Pregnancies With Abnormal Uterine Perfusion

From the Department of Obstetrics and Gynecology (H.S., A.U., R.F.), University of Leipzig, Leipzig, Germany; and the Department of Physics (N.W.), University of Potsdam, Potsdam, Germany.

Correspondence to Holger Stepan, Department of Obstetrics and Gynecology, Philipp-Rosenthalstr 55, 04103 Leipzig, Germany. E-mail holger.stepan{at}medizin.uni-leipzig.de

Angiogenic factors like placental growth factor and its antiangiogenic antagonist soluble fms-like tyrosine kinase 1 (sFlt1) are closely related to the pathogenesis of preeclampsia and intrauterine growth restriction. Because it is known that altered maternal sFlt1 and placental growth factor levels are detectable weeks before the onset of these pregnancy complications, it was the aim of the study to investigate the predictive value of these markers in high-risk second trimester pregnancies characterized by abnormal uterine perfusion. This prospective study includes 63 second trimester pregnant women with abnormal uterine perfusion. Twenty five of them developed a later complication (12 with preeclampsia, 11 with intrauterine growth restriction, and 2 with intrauterine death), whereas 38 had a normal course of pregnancy. Pregnancies with adverse pregnancy outcome showed in the second trimester significantly higher sFlt1 (1403.6±555 versus 451.8±42 pg/mL; P<0.05) and lower placental growth factor (139.6±24 versus 184.1±21 pg/mL) levels compared with those with normal outcome. These alterations were more pronounced in pregnancies with subsequent preeclampsia compared with intrauterine growth restriction and early onset diseases (delivery <34 weeks) compared with late-onset diseases. The combination of Doppler and sFlt1 increases the sensitivity of Doppler alone for iatrogenic preterm delivery from 64% up to 79% and the specificity from 63% up to 80%. Using both factors, sFlt1 and placental growth factor, early onset preeclampsia can be predicted with 83% sensitivity and 95% specificity. We conclude that the concurrent measurement of uterine perfusion and angiogenic factors allows an efficient prediction of early onset pregnancy complications, particularly preeclampsia.

Key Words: angiogenic factors • Doppler sonography • intrauterine growth restriction • preeclampsia • uterine perfusion

This article has been cited by other articles:

				L. C.Y. Poon, N. A. Kametas, N. Maiz, R. Akolekar, and K. H. Nicolaides First-Trimester Prediction of Hypertensive Disorders in Pregnancy Hypertension, May 1, 2009; 53(5): 812 - 818. [Abstract] [Full Text] [PDF]

				S. E. Maynard and R. Thadhani Pregnancy and the Kidney J. Am. Soc. Nephrol., January 1, 2009; 20(1): 14 - 22. [Abstract] [Full Text] [PDF]

				B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]

				M. Fasshauer, T. Waldeyer, J. Seeger, S. Schrey, T. Ebert, J. Kratzsch, U. Lossner, M. Bluher, M. Stumvoll, R. Faber, et al. Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function Eur. J. Endocrinol., February 1, 2008; 158(2): 197 - 201. [Abstract] [Full Text] [PDF]

				S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al. Uterine Vascular Function in a Transgenic Preeclampsia Rat Model Hypertension, February 1, 2008; 51(2): 547 - 553. [Abstract] [Full Text] [PDF]

				S. Rana, S. A. Karumanchi, R. J. Levine, S. Venkatesha, J. A. Rauh-Hain, H. Tamez, and R. Thadhani Sequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing Preeclampsia Hypertension, July 1, 2007; 50(1): 137 - 142. [Abstract] [Full Text] [PDF]